1.18 USD
↗ 0.02 (1.72%)AT CLOSE (03:59 PM EST)
Chemomab Therapeutics Ltd. American Depositary Share
CMMBNASDAQ • USD
1.18
↗ 0.00 (0.34%)
POST MARKET (AS OF 04:12 PM EST)
Post Market
AS OF 04:12 PM EST
1.18
↗ 0.00 (0.34%)
Market: OPEN
CMMB is currently priced at $1.18. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 2, 2026.
Open?$1.22
High?$1.23
Low?$1.15
Prev. Close?$1.16
Volume?76.4K
Avg. Volume?99.9K
VWAP?$1.18
Rel. Volume?0.77x
Bid / Ask
Bid?$0.99 × 100
Ask?$1.40 × 100
Spread?$0.41
Midpoint?$1.19
Valuation & Ratios
Market Cap?8.5M
Shares Out?7.2M
P/E Ratio?N/A
P/B Ratio?0.30
EPS?-$4.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Address
KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-14.53Distress
Confidence?46%Low
Short InterestLow
Short Interest?13.9K
Days to Cover?1.0
Avg Daily Volume43.0K
Settlement Date2026-10-15
Financial Health
Current Ratio?4.83Strong
Quick Ratio?4.83Strong
Cash Ratio?2.97Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.30CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-111.9%WEAK▾
S&P3
ROA?-89.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-23900000
Enterprise Value?$-12264914
Fundamentals ratios updated end of day